Peter Openshaw, PhD

Imperial College London, United Kingdom

Disclosure(s): Bavarian Nordic: Advisor/Consultant; Cepheid: Advisor/Consultant; GlaxoSmithKline: Advisor/Consultant; Janssen: Advisor/Consultant; Pfizer: Advisor/Consultant

Poster(s):

• 260 - Corticosteroid treatment in influenza virus and SARS-CoV-2 co-infected patients
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET